title: 2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006.
abstract: Chronic heart failure (CHF) is a complex and lethal clinical syndrome accounting for an increasing number of Australian hospital separations and more than 2700 Australian deaths in 2008. In 2006, the National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand published Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Results from recently published clinical trials provide additional information to be considered in the prevention, detection and management of CHF. In some cases, this new evidence strengthens recommendations previously made in the 2006 guidelines; in others, it provides new approaches to current recommended practice. Areas in which there have been significant new developments include: Use of B-type natriuretic peptide (BNP) or N-terminal proBNP plasma level measurement in guiding treatment of CHF; New pharmacological approaches to the treatment of systolic heart failure; Drugs to avoid or use with caution in CHF; Treatment of cardiac arrhythmias in patients with CHF; Multidisciplinary care and post-discharge management programs. While patient circumstances and clinical judgement should guide the interpretation of these findings in the clinical context, this update, together with the 2006 guidelines, provides current clinical guidance on CHF.
authors.affiliation: Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC. henry.krum@monash.edu
authors.forename: Henry
authors.initials: H
authors.lastname: Krum
authors.forename: Michael V
authors.initials: MV
authors.lastname: Jelinek
authors.forename: Simon
authors.initials: S
authors.lastname: Stewart
authors.forename: Andrew
authors.initials: A
authors.lastname: Sindone
authors.forename: John J
authors.initials: JJ
authors.lastname: Atherton
mesh_terms: D001315:Australia; D006348:Cardiac Surgical Procedures; D002317:Cardiovascular Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D009520:New Zealand; D017410:Practice Guidelines as Topic
chemical_list: D002317:Cardiovascular Agents